Pharmaceuticals, Biotechnology and Life Sciences
Novartis could have the first therapy which could delay disability progression secondary progressive multiple sclerosis (SPMS) if it gets the…
GlaxoSmithKline got the approval for shingles prevention, and post-herpetic neuralgia (PHN) vaccine Shingrix, in Europe, while in Japan it was registered…
The Japanese Ministry of Health, Labour and Welfare has approved Novo Nordisk’s treatment for type 2 diabetes adult patients, new…
CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity…
Immune cells called microglia can completely repopulate themselves in the retina after being nearly eliminated, according to a new study…
As we grow older we are faced with an increased number of health conditions that can not only be very…
Should I get breast implants? Are there alternatives? Will they need to be replaced? And if I decide to get…
Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…
The U.S. Food and Drug Administration on Tuesday approved Saettle Genetics’s Adcetris (brentuximab vedotin) to treat adult patients with previously…
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…